Quantum proteolysis by neutrophils: Implications for pulmonary emphysema in α1-antitrypsin deficiency

Journal of Clinical Investigation

Volumn 104, Issue 3, 1999, Pages 337-344

  Campbell, Edward J ^a   Campbell, Melody A ^a   Boukedes, Steve S ^a   Owen, Caroline A ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ENZYME KINETICS; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LUNG EMPHYSEMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0032743423     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6092     Document Type: Article

References (50)

1. Laurell, C.-B., and Eriksson, S. 1963. The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15:132-140.
2. Liou, T.G., and Campbell, E.J. 1995, Non-isotropic enzyme-inhibiror interactions: a novel non-oxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry. 34:16171-16177.
3. Owen, C.A., et al. 1994. A discrete subpopulation of human monocytes expresses a neutrophil-like pro-inflammatory (P) phenotype. Am. J. Physiol. 267:L775-L785.
4. Janoff, A. 1985. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir.Dis. 132:417-433.
5. 1-antitrypsin phenotypes. Chest. 100:703-708.
6. Hurchison, D.C.S. 1988. Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med. 84(Suppl. 6A):3-12.
7. Turino, G.M., et al. 1996. Clinical features of individuals with Pi *SZ phenotype of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Am. J. Respir. Crit. Care Med. 154:1718-1725.
8. 1-proteinase inhibitor to protect lung elastin from elastolytic degradation. Hoppe Seylers Z. Physiol. Chem. 365:731-736.
9. 1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 80:1366-1374.
10. Llewellyn-Jones, CG., Lomas, D.A., and Stockley, R.A. 1994. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax. 49:567-572.
11. Liou, T.G., and Campbell, E.J. 1996. Quantum proteolysis resulting from release of single granules by neutrophils: a novel, non-oxidative mechanism of extracellular proteolytic activity. J. Immunol 157:2624-2631.
12. Pierce, J.A., and Eradio, B.G. 1979. Improved identification of antitrypsin phenotypes through isoelectric focusing with dithioerythritol. J. Lab. Clin. Med. 94:826-831.
13. Silverman, E.K., et al. 1989. Alpha 1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am Rev. Respir. Dis. 140:961-966.
14. Boyum, A, 1963. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97:77-89.
15. Crank. J. 1975. The mathematics of diffusion. Oxford University Press. New York, NY. 28-43.
16. Baugh, R.J., and Travis, J. 1976. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry. 15:836-841.
17. Ohlsson, K., and Olsson, I. 1974. The neutral proteases of human granulocytes: isolation and partial characterization of granulocyte elastase. Eur. J. Biochem. 42:519-527.
18. Damiano, V.V., Kucich, U., Murer, E., Laudenslager, N., and Weinbaum, G. 1988. Ultrastructural qualification of peroxidase- and elastase-containing granules in human neutrophils. Am. J. Pathol. 131:235-245.
19. Campbell, E.J., and Campbell, M.A. 1988. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J. Cell Biol. 106:667-676.
20. 1-pantitrypsin to prevent neutrophil mediated tissue damage. Biochim. Biophys. Acta. 1227:155-160.
21. 1-antitrypsin deficiency. Acta Med. Scand. 175:197-205.
22. Beatty, K., Bieth, J., and Travis, J. 1980. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255:3931-3934.
23. Shapiro, S.D. 1995. The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. Proc. Assoc. Am. Physicians. 107:346-352.
24. Senior, R.M., et al. 1977. The induction of pulmonary emphysema with human leukocyte elastase. Am Rev. Respir. Dis. 116:469-475.
25. Janoff, A., et al. 1977. Experimental emphysema induced with purified human neutrophil elastase. Tissue localization of the instilled protease. Am. Rev. Respir. Dis. 115:461-478.
26. 1-proteinase inhibitor. J. Clin. Invest. 89:766-773.
27. Larsson, C., Eriksson, S., and Dirksen, H. 1977. Smoking and intermediate alpha 1-antitrypsin deficiency and lung function in middle-aged men. Br. Med J. 2:922-925.
28. 1-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. Am. Rev. Respir.Dis. 114:1077-1084.
29. Fagerhol, M.K., and Hauge, H.E. 1969. Serum Pi types in patients with pulmonary diseases. Acta Allergol. 24:107-114.
30. Cole, et al. 1976. Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population. Thorax. 31:149-157.
31. 1-antitrypsin deficiency: clinical and physiological features in heterozygotes of type Pi SZ. A survey by the British Thoracic Association. Br. J. Dis. Chest. 77:28-34.
32. 1-antitrypsin deficiency: a case-control study. Am. Rev. Respir Dis 120:759-766.
33. Mittman, C. 1978. The PiMZ phenotype: is it a significant risk factor for the development of chronic obstructive lung disease? Am. Rev. Respir. Dis. 118:649-652.
34. 4 by alveolar macrophages J. Clin. Invest. 88:891-897.
35. Bedard, M., et al. 1993. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9:455-462.
36. Nakamura, H., Yoshimura, K., McElvaney, N.G., and Crystal, R.G. 1992. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89:1478-1484.
37. Elzouki, A.N., Segelmark, M., Wieslander, J., and Eriksson, S. 1994. Strong link between the alpha 1-antitrypsin Pi Z allele and Wegener's granulomatosis. J. Intern. Med. 236:543-548.
38. 1-antitrypsin deficiency. QJM. 89:599-611.
39. Callea, F., et al. 1997. Alpha 1-antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications. Eur. J. Clin. Invest. 27:696-702.
40. O'Donoghue, D.J., Guickian, M., Blundell, G., and Winney, R.J. 1993. Alpha-1-proteinase inhibitor and pulmonary haemorrhage in systemic vasculitis. Adv. Exp. Med. Biol. 336:331-335.
41. Su, W.P., Smith, K.C., Pittelkow, M.R., and Winkelmann, R.K. 1987. Alpha 1-antitrypsin deficiency panniculitis: a histopathologic and immunopathologic study of four cases. Am. J. Dermatopathol. 9:483-490.
42. Bleumink, E., and Klokke, H.A. 1984. Protease-inhibitor deficiencies in a patient with Weber-Christian panniculitis. Arch. Dermatol. 120:936-940.
43. Lewis, M., et al. 1985. Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. Am J. Med. 79:489-494.
44. 1-antitrypsin deficiency associated with emphysema. N. Engl. J. Med. 316:1055-1062.
45. Schneeberger, E.E. 1979. Barrier function of intercellular junctions in adult and fetal lungs. In Pulmonary edema. A.P. Fishman and E.M. Renkin, editors. American Physiological Society. Bethesda, MD. 21-37.
46. Gorin, A.B., and Stewart, P.A. 1979. Differential permeability of endothelial and epithelial barriers to albumin flux. J. Appl. Physiol. 47:1315-1324.
47. Brigham, K.L., and Owen, P.J. 1975. Increased sheep lung vascular permeability caused by histamine. Circ. Res. 37:647-657.
48. Brigham, K.L., and Owen, P.J. 1975. Mechanism of the serotonin effect on lung transvascular fluid and protein movement in awake sheep. Circ. Res. 36:761-770.
49. 1-antitrypsin. Am. J. Respir. Crit. Care Med. 158:49-59.
50. 1-antitrypsin deficiency? Eur. Respir. J. 10:2260-2263.